Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Formyl peptide receptor 2 regulates dendritic cell metabolism and Th17 cell differentiation during neuroinflammation

JH. Lim, A. Neuwirth, KJ. Chung, S. Grossklaus, O. Soehnlein, G. Hajishengallis, T. Chavakis

. 2024 ; 15 (-) : 1354074. [pub] 20240801

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24019433

Grantová podpora
R01 DE029436 NIDCR NIH HHS - United States

Formyl peptide receptor 2 (FPR2) is a receptor for formylated peptides and specific pro-resolving mediators, and is involved in various inflammatory processes. Here, we aimed to elucidate the role of FPR2 in dendritic cell (DC) function and autoimmunity-related central nervous system (CNS) inflammation by using the experimental autoimmune encephalomyelitis (EAE) model. EAE induction was accompanied by increased Fpr2 mRNA expression in the spinal cord. FPR2-deficient (Fpr2KO) mice displayed delayed onset of EAE compared to wild-type (WT) mice, associated with reduced frequencies of Th17 cells in the inflamed spinal cord at the early stage of the disease. However, FPR2 deficiency did not affect EAE severity after the disease reached its peak. FPR2 deficiency in mature DCs resulted in decreased expression of Th17 polarizing cytokines IL6, IL23p19, IL1β, and thereby diminished the DC-mediated activation of Th17 cell differentiation. LPS-activated FPR2-deficient DCs showed upregulated Nos2 expression and nitric oxide (NO) production, as well as reduced oxygen consumption rate and impaired mitochondrial function, including decreased mitochondrial superoxide levels, lower mitochondrial membrane potential and diminished expression of genes related to the tricarboxylic acid cycle and genes related to the electron transport chain, as compared to WT DCs. Treatment with a NO inhibitor reversed the reduced Th17 cell differentiation in the presence of FPR2-deficient DCs. Together, by regulating DC metabolism, FPR2 enhances the production of DC-derived Th17-polarizing cytokines and hence Th17 cell differentiation in the context of neuroinflammation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019433
003      
CZ-PrNML
005      
20241024110717.0
007      
ta
008      
241015e20240801sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2024.1354074 $2 doi
035    __
$a (PubMed)39148732
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Lim, Jong-Hyung $u Laboratory of Innate Immunity and Inflammation, Department of Basic and Translational Sciences, Penn Dental Medicine, University of Pennsylvania, Philadelphia, PA, United States $u Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany
245    10
$a Formyl peptide receptor 2 regulates dendritic cell metabolism and Th17 cell differentiation during neuroinflammation / $c JH. Lim, A. Neuwirth, KJ. Chung, S. Grossklaus, O. Soehnlein, G. Hajishengallis, T. Chavakis
520    9_
$a Formyl peptide receptor 2 (FPR2) is a receptor for formylated peptides and specific pro-resolving mediators, and is involved in various inflammatory processes. Here, we aimed to elucidate the role of FPR2 in dendritic cell (DC) function and autoimmunity-related central nervous system (CNS) inflammation by using the experimental autoimmune encephalomyelitis (EAE) model. EAE induction was accompanied by increased Fpr2 mRNA expression in the spinal cord. FPR2-deficient (Fpr2KO) mice displayed delayed onset of EAE compared to wild-type (WT) mice, associated with reduced frequencies of Th17 cells in the inflamed spinal cord at the early stage of the disease. However, FPR2 deficiency did not affect EAE severity after the disease reached its peak. FPR2 deficiency in mature DCs resulted in decreased expression of Th17 polarizing cytokines IL6, IL23p19, IL1β, and thereby diminished the DC-mediated activation of Th17 cell differentiation. LPS-activated FPR2-deficient DCs showed upregulated Nos2 expression and nitric oxide (NO) production, as well as reduced oxygen consumption rate and impaired mitochondrial function, including decreased mitochondrial superoxide levels, lower mitochondrial membrane potential and diminished expression of genes related to the tricarboxylic acid cycle and genes related to the electron transport chain, as compared to WT DCs. Treatment with a NO inhibitor reversed the reduced Th17 cell differentiation in the presence of FPR2-deficient DCs. Together, by regulating DC metabolism, FPR2 enhances the production of DC-derived Th17-polarizing cytokines and hence Th17 cell differentiation in the context of neuroinflammation.
650    _2
$a zvířata $7 D000818
650    12
$a dendritické buňky $x imunologie $x metabolismus $7 D003713
650    12
$a receptory pro formylované peptidy $x genetika $x metabolismus $7 D044042
650    12
$a buňky Th17 $x imunologie $x metabolismus $7 D058504
650    _2
$a myši $7 D051379
650    12
$a encefalomyelitida autoimunitní experimentální $x imunologie $x metabolismus $7 D004681
650    12
$a buněčná diferenciace $7 D002454
650    12
$a myši knockoutované $7 D018345
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a cytokiny $x metabolismus $7 D016207
650    _2
$a neurozánětlivé nemoci $x imunologie $x metabolismus $7 D000090862
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a mícha $x imunologie $x metabolismus $7 D013116
655    _2
$a časopisecké články $7 D016428
700    1_
$a Neuwirth, Ales $u Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany $u Laboratory of Adaptive Immunity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
700    1_
$a Chung, Kyoung-Jin $u Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany
700    1_
$a Grossklaus, Sylvia $u Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany
700    1_
$a Soehnlein, Oliver $u Institute for Experimental Pathology, Center for Molecular Biology of Inflammation, University of Münster, Münster, Germany
700    1_
$a Hajishengallis, George $u Laboratory of Innate Immunity and Inflammation, Department of Basic and Translational Sciences, Penn Dental Medicine, University of Pennsylvania, Philadelphia, PA, United States
700    1_
$a Chavakis, Triantafyllos $u Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 15 (20240801), s. 1354074
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39148732 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024110711 $b ABA008
999    __
$a ok $b bmc $g 2201958 $s 1231406
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 15 $c - $d 1354074 $e 20240801 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
GRA    __
$a R01 DE029436 $p NIDCR NIH HHS $2 United States
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...